Fermenta Biotech

₹455.00As of Sun 8 Nov 2026, 12:00 UTC

NSE:FERMENTA—

Country India

PE (Fwd) 17.85

TSR 10Y CAGR —

Div yield 0.82%

ROE —

Pharmaceutical Preparations

Beta (5Y) (0.23)

PE TTM 18.56

TSR TTM —

Mkt cap ₹12.36B

ROIC —

SE Grade™

—

Value

—

Quality

Moat

—

1Y Price

Reference

₹493

—

8.41%

—

FY23

FY24

FY25

FY26

Earnings per share₹

(17.70)

(7.99)

26.35

24.51

(432.08%)

54.86%

429.79%

(6.98%)

Revenue₹B

3.499

3.357

4.695

5.254

(12.19%)

(4.08%)

39.87%

11.92%

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

5.254

Revenue₹B

—

3.985

3.499

3.357

4.695

5.254

5.537

7.16%

11.92

Revenue growth%

—

(12.19)

(4.08)

39.87

11.92

5.38

3.92

—

59.23

Gross margin%

—

58.09

51.47

54.29

60.72

59.23

59.02

58.09

14.87

Operating margin%

—

9.03

(2.95)

0.93

19.29

14.87

14.50

9.03

13.66

Net margin%

—

3.88

(14.60)

(6.87)

16.37

13.66

13.08

3.88

18.56

P/E ratio (avg)x

—

18.39

—

17.05

EV/EBITx

—

16.59

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

24.51

EPS₹

—

5.33

(17.70)

(7.99)

26.35

24.51

24.74

46.47%

—

(6.96)

EPS growth%

—

(432.31)

54.88

429.89

(6.96)

0.93

23.96

—

Bookvalue per sh₹

—

FCF per share₹

—

3.75

Dividend per sh₹

—

1.25

2.50

3.75

4.11

31.61%

—

0.82

Div yield (avg)%

—

0.90

—

15.30

Payout ratio%

—

23.45

—

9.49

15.30

16.62

15.30

—

29.28

Shares (diluted)M

—

29.00

28.86

28.87

29.17

29.28

◌29.28

0.24%

(0.35)

Buyback yield%

—

0.50

(0.06)

(1.04)

(0.35)

◌—

(0.20)

—

D/E ratiox

—

13.32

Enterprise value₹B

—

13.32

—

LT debt₹M

—

Peers (US$136.5M)

Cap (US$)

Bharat Parenterals…

136.0M

1,303x

Sudarshan Pharma…

86.44M

26.89x

Trident Lifeline…

52.57M

21.04x

MPH Health Care AG

137.0M

2.520x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

6.772

2.211

Own earn%

—

Sh yield%

0.47

(0.20)

Owners

Insiders/Inst%

66.67

0.01

Short interest%

—

SBC / revenue%

0.84

Record

10Y

Profitable years

3/5

Revenue growth years

2/4

EPS growth years

2/4

Dividend streakyrs

Op margin range%

−3–19

$1 testx

—

Incr. ROIC%

—

Fermenta Biotech Limited, together with its subsidiaries, engages in the manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products in India, Europe, the United States, and internationally. It operates through Chemicals/Bulk Drug and Property segments.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹5.254B

7.16%

1.00×

Cost of revenue

₹2.142B

6.42%

0.97×

Operating expenses

₹2.331B

4.49%

0.90×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m